Royalty Pharma plc (RPRX) Institutional Ownership

Institutions by Trading Activity

Ownership Statistics

564,455,000Shares Outstanding

368,092,533Shares held by institutions

$17,841,445,075Value of institutional holdings

65.21%Institutional ownership %

12.49%Shares Changed QoQ

527No. of institutional investors

Shares Owned by Institutions

Shares Purchased/Sold by Institutions

Ownership Summary

Royalty Pharma plc (NASDAQ:RPRX) appears in 527 institutional 13F filings for the quarter ending December 2025.

They owned 64.9% of outstanding stock in December 2025, up from 59.6% the prior quarter.
Their total shares held in RPRX increased 12.24% from the prior quarter, while the number of investors in Royalty Pharma increased 26.99% year over year.
Of these 527 holders, 331 added to their stakes in Royalty Pharma, 134 trimmed positions, and 62 made no changes.
Altogether, these fund groups held 366.34Mn shares in RPRX by December 2025, up by 39.96Mn shares quarter on quarter, and down 2.43Mn shares year over year.
As of December 31, 2025, the biggest holder of Royalty Pharma is Ridgewood Investments LLC at 4.56K shares, representing 0.0% of shares outstanding.
The largest buyers of Royalty Pharma for the quarter ending December 2025 were Ridgewood Investments LLC (4.56K).
Business Quant data shows the 2 biggest positions in Royalty Pharma as of December 2025 are held by Ridgewood Investments LLC (4.56K), Sankala Group LLC (197).

527 Institutional Holders

368,092,533 Total Shares Held

Rows:

Download Data

Owner Name	Date	Shares Held	Change (QoQ)	Change (%)	Value (USD)
Morgan Stanley	31 Dec, 2025	55,274,069	11,110,115	25.16%	$2,135,790,095.00
Capital International Investors	31 Dec, 2025	31,104,309	3,891,615	14.30%	$1,201,870,500.00
FMR LLC	31 Dec, 2025	26,272,308	-1,714,406	-6.13%	$1,015,161,996.00
BlackRock, Inc.	31 Dec, 2025	26,188,692	-11,811	-0.05%	$1,011,931,068.00
Swedbank AB	31 Dec, 2025	23,884,286	11,684,016	95.77%	$922,888,812.00
BAILLIE GIFFORD & CO	31 Dec, 2025	17,008,768	-363,734	-2.09%	$657,218,795.00
ADAGE CAPITAL PARTNERS GP, L.L.C.	31 Dec, 2025	11,740,594	-225,039	-1.88%	$453,656,552.00
State Street Corp	31 Dec, 2025	10,649,641	376,888	3.67%	$411,502,128.00
VANGUARD GROUP INC	31 Dec, 2025	9,934,612	-1,001,926	-9.16%	$383,873,407.00
GEODE CAPITAL MANAGEMENT, LLC	31 Dec, 2025	7,719,843	102,430	1.34%	$297,465,419.00
Caledonia (Private) Investments Pty Ltd	31 Dec, 2025	7,377,038	-170,571	-2.26%	$285,048,748.00
CITADEL ADVISORS LLC	31 Dec, 2025	5,273,865	4,879,192	1,236.26%	$203,782,144.00
VICTORY CAPITAL MANAGEMENT INC	31 Dec, 2025	5,106,905	449,498	9.65%	$197,330,809.00
JANE STREET GROUP, LLC	31 Dec, 2025	4,947,409	1,795,749	56.98%	$191,167,884.00
Northern Trust Corp	31 Dec, 2025	4,003,322	-71,917	-1.76%	$154,688,363.00
NORGES BANK	31 Dec, 2025	3,414,165	3,414,165	0.00%	$131,923,336.00
Patient Capital Management, LLC	31 Dec, 2025	3,333,675	215,825	6.92%	$128,813,194.00
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	31 Dec, 2025	3,313,265	31,091	0.95%	$128,024,560.00
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	31 Dec, 2025	3,118,865	-11,071	-0.35%	$120,512,944.00
Goldman Sachs Group Inc	31 Dec, 2025	3,101,800	1,456,173	88.49%	$119,853,554.00

1 - 20 of 527

Research Tools